Biomarkers are increasingly used in gynecological testing to diagnose and monitor various conditions. For example, CA-125 is a biomarker used to detect ovarian cancer, while HE4 and ROMA (Risk of Ovarian Malignancy Algorithm) are used for risk assessment. Biomarkers provide valuable information about disease presence, progression, and response to treatment.
